Feasibility study of S-1 and weekly cisplatin in patients received R0 resection for Stage IIB and III gastric cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 26 Aug 2016
At a glance
- Drugs Cisplatin (Primary) ; Gimeracil/oteracil/tegafur (Primary)
- Indications Gastric cancer
- Focus Therapeutic Use
- 20 Jul 2016 Status changed from recruiting to active, no longer recruiting.
- 13 May 2013 Planned end date added (1 Mar 2018) as reported by University Hospital Medical Information Network - Japan record.
- 17 May 2011 New trial record